» Articles » PMID: 39211797

Unraveling the Complex Interplay: Immunopathology and Immune Evasion Strategies of Alphaviruses with Emphasis on Neurological Implications

Abstract

Arthritogenic alphaviruses pose a significant public health concern due to their ability to cause joint inflammation, with emerging evidence of potential neurological consequences. In this review, we examine the immunopathology and immune evasion strategies employed by these viruses, highlighting their complex mechanisms of pathogenesis and neurological implications. We delve into how these viruses manipulate host immune responses, modulate inflammatory pathways, and potentially establish persistent infections. Further, we explore their ability to breach the blood-brain barrier, triggering neurological complications, and how co-infections exacerbate neurological outcomes. This review synthesizes current research to provide a comprehensive overview of the immunopathological mechanisms driving arthritogenic alphavirus infections and their impact on neurological health. By highlighting knowledge gaps, it underscores the need for research to unravel the complexities of virus-host interactions. This deeper understanding is crucial for developing targeted therapies to address both joint and neurological manifestations of these infections.

Citing Articles

Eastern equine encephalitis virus: Pathogenesis, immune response, and clinical manifestations.

Parashar B, Malviya R, Sridhar S, Wadhwa T, Talath S, Shareef J Infect Med (Beijing). 2025; 4(1):100167.

PMID: 40026316 PMC: 11869868. DOI: 10.1016/j.imj.2025.100167.


Neuropathogenesis of Old World Alphaviruses: Considerations for the Development of Medical Countermeasures.

Lantz A, Baxter V Viruses. 2025; 17(2).

PMID: 40007016 PMC: 11860675. DOI: 10.3390/v17020261.


Ocular neuroinflammatory response secondary to SARS-CoV-2 infection-a review.

Zhao Y, Tang Y, Wang Q, Li J Front Immunol. 2025; 16:1515768.

PMID: 39967658 PMC: 11832381. DOI: 10.3389/fimmu.2025.1515768.

References
1.
Couderc T, Khandoudi N, Grandadam M, Visse C, Gangneux N, Bagot S . Prophylaxis and therapy for Chikungunya virus infection. J Infect Dis. 2009; 200(4):516-23. PMC: 7109959. DOI: 10.1086/600381. View

2.
Wongchitrat P, Chanmee T, Govitrapong P . Molecular Mechanisms Associated with Neurodegeneration of Neurotropic Viral Infection. Mol Neurobiol. 2023; 61(5):2881-2903. PMC: 11043213. DOI: 10.1007/s12035-023-03761-6. View

3.
Touret Y, Randrianaivo H, Michault A, Schuffenecker I, Kauffmann E, Lenglet Y . [Early maternal-fetal transmission of the Chikungunya virus]. Presse Med. 2006; 35(11 Pt 1):1656-1658. DOI: 10.1016/S0755-4982(06)74874-6. View

4.
Griffin D . Molecular pathogenesis of Sindbis virus encephalitis in experimental animals. Adv Virus Res. 1989; 36:255-71. DOI: 10.1016/s0065-3527(08)60587-4. View

5.
Pal P, Fox J, Hawman D, Huang Y, Messaoudi I, Kreklywich C . Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes. J Virol. 2014; 88(15):8213-26. PMC: 4135940. DOI: 10.1128/JVI.01032-14. View